Project Details
Description
All studies to be done in C57Bl6 mice and AGN-751 will be given orally.
Control group data are available from prior studies with NRX-1074. We will additional mice to the control group to confirm previous control data; this will enable us to have more groups to interrogate the effects of AGN-751 and more extensively compare with data we have obtained with rapastinel and NRX-1074.
Status | Finished |
---|---|
Effective start/end date | 9/13/18 → 8/31/20 |
Funding
- Allergan Sales, LLC (IS00009332)
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.